Publications

Clinical Trial Sites

Clinical Application - Internal Medicine

Clinical Application - Surgery

Preclinical Studies

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

Malignant pleural effusion (MPE) refers to pleural effusion caused by a primary malignant tumor of the pleura or by metastasis of a malignant tumor from other sites to the pleura.

Release time:

2026-11-12

Source:

Related Information

“Core Public Education Knowledge for Cancer Patient Management in China (2026)” — HIPEC Technology Section

2026 CSCO Guidelines for the Diagnosis and Treatment of Colorectal Cancer

Expert Consensus on the Diagnosis and Treatment of Malignant Pleural and Peritoneal Effusions

Chinese Expert Consensus on the Diagnosis and Treatment of Pseudomyxoma Peritonei

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

Chinese Expert Consensus on the Diagnosis and Treatment of Malignant Peritoneal Mesothelioma in Women (2026 Edition)

Advances in the application of hyperthermic intrathoracic chemotherapy for the treatment of malignant thoracic tumors

Chinese Expert Consensus on Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer (2026 Edition)

Current Status and Prospects of Intraperitoneal Hyperthermic Perfusion Chemotherapy in the Treatment of Gastric Cancer

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

Anovel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer

Reprinted: Clinical and Imaging Scoring of Peritoneal Carcinomatosis

Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Gastric Cancer 2026

Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy

Good Doctor Animal Experiment | Animal experiment comparing the flow rate and temperature of intraperitoneal hyperthermic perfusion chemotherapy with three different catheterization methods August 2022 Modern Oncology Medicine - Volume 30, Issue 15

Good Doctor
Good Doctor

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

WeChat Public Number
Mobile phone station

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Copyright  Xi'an Good Doctor Medical Technology Co., Ltd.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Powered by www.300.cn

Sorry，The current column has no content!

You can view other columns or return Home